The abstract is read at the publisher; the summary is JClub's.
Renal tumor biopsy in renal cell carcinoma yields a pooled diagnostic yield of 90%, with sensitivity of 99% and specificity of 85% for malignancy.
- Why it matters: Clinicians need reliable tissue diagnosis for renal masses while minimizing harm and clarifying whether biopsy results meaningfully change management decisions.
- What they did: A systematic review and meta-analysis of 103 studies synthesized diagnostic performance with hierarchical bivariate random-effects models and assessed concordance, complications, and clinical impact.
- The result: Complications were low at 3% with negligible (<1%) Clavien-Dindo ≥3 events, and biopsy findings changed management in 39% and avoided active treatment in 28%.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.